Maduck Sean sold CORT
February 3, 2025 · Form 4 insider transaction
Maduck Sean sold 20,000 shares of Corcept Therapeutics Incorporated at $66.92 per share, a transaction worth $1.34M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.; Includes 636 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024 and 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.